Tivic Health Systems ( (TIVC) ) just unveiled an announcement.
Tivic Health Systems, Inc. has entered into an agreement with Maxim Group LLC to potentially sell shares of common stock, allowing sales through various methods including “at the market” offerings. The company may sell up to $10 million worth of shares, with the agreement ending in 24 months or upon meeting other conditions. Concurrently, Tivic announced a leadership change with Lisa Wolf appointed as the new interim CFO starting October 1, 2024, taking over from Kimberly Bambach who will continue as an advisor. This comes as Tivic advances in bioelectronic medicine with products like their FDA-approved ClearUP sinus treatment device.
For a thorough assessment of TIVC stock, go to TipRanks’ Stock Analysis page.
